Pioneering new treatments through cutting-edge research and translational drug development.

Pioneering sustainable solutions with world-class fabrication, characterisation, and industry-ready innovation.

Monash’s research infrastructure unites world-class facilities, technologies, and expertise across four key capability areas: drug discovery and development, biomedical and life sciences, advanced ...

Provides expertise in advanced electron microscopy for biomedical discoveries at molecular and cellular level. Provides a comprehensive service in animal and cell genome modification as well as DNA ...

Monash University spinout RAGE Biotech has raised $29 million in Series A funding, marking a major step toward translating ...

Adherence to cholesterol-lowering treatments remains one of the biggest challenges in preventing heart disease. The one-time ...

Financial insecurity is affecting most young Australians, according to new research from Monash University.

The study also revealed that harassment experienced during adolescence continues to affect women’s perceptions of safety well ...

The AI for Law Enforcement and Community Safety (AiLECS) Lab, a collaboration between the AFP and Monash University, is developing a new disruption tool which, among its broad applications, can slow ...

“Highly Cited researchers are synonymous with excellence. This year’s result, with 27 Monash researchers identified on the Clarivate list, continues a trend of growing our HiCi cohort, increasing from ...

Existing evidence does not clearly link paracetamol (acetaminophen) use during pregnancy with autism or ADHD in children, finds an in-depth evidence review published by The BMJ, in direct response to ...

Seven researchers from across Monash have been newly appointed to the Australian Research Council College of Experts for 2026 - a recognition of their outstanding research excellence, leadership and ...